Skip to content

Effect of stellate ganglion block on postoperative recovery quality of perimenopausal gynecological patients undergoing laparoscopic surgery

Effect of stellate ganglion block on postoperative recovery quality of perimenopausal gynecological patients undergoing laparoscopic surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057907
Enrollment
Unknown
Registered
2022-03-21
Start date
2022-03-22
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endoscopic surgery in gynecology

Interventions

Experimental group:4 mL of 0.2% ropivacaine was injected into the right stellate ganglion
Control group:4mL normal saline was injected into the right stellate ganglion

Sponsors

South Hospital of Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 40 and 60 years; 2. ASA grade I-II; 3. BMI (Body Mass Index) 20 IU/L at initial diagnosis; 6. Patients with menopausal symptoms had improved Kupperman score >= 7 at initial diagnosis; 7. Voluntarily participate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Contraindications of stellar ganglion block: local anesthetic allergy, neck mobility disorder, infection, ulcer, burn and injury of the skin around the nerve block site; history of chronic pain, long-term use of analgesics; 2. Complicated with electrolyte disorders, acidosis, endocrine diseases, serious heart, liver and kidney diseases, mental diseases, sleep disorders, cognitive disorders; 3. Recently used anti-anxiety drugs, sedative hypnotic drugs, anti-vomiting drugs; 4. Communication breakdown.

Design outcomes

Primary

MeasureTime frame
40-item quality of recovery (QoR-40) questionnaire;

Countries

China

Contacts

Public ContactXiaodan Wu

South Hospital of Fujian Provincial Hospital

wxiaodan@sina.com+86 13055291720

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026